Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
automatically, breach, chloride, Conn, deliver, delivered, fact, free, Grace, Healthspan, independent, kilogram, nicotinamide, redeemed, resale, resell, riboside, Rob, shelf, shipped, slight, subcontracted, unanimously, work, worth
Removed:
appointed, client, serve
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 Exclusive Supply Agreement, Effective As of August 27, 2015 Between Healthspan Research, LLC. and Chromadex, Inc.
- 10.2 Limited Liability Company Agreement, Effective As of August 27, 2015 Between Healthspan Research LLC and Chromadex, Inc.
- 10.3 Interest Purchase Agreement, Effective As of August 27, 2015 Between Healthspan Research LLC and Chromadex, Inc.
- 10.4 Take or Pay Purchase Agreement for Nicotinamide Riboside Chloride, Effective As of September 21, 2015, Between W.R. Grace & Co. Conn. and Chromadex, Inc.
- 10.5 Supply Agreement, Effective As of August 28, 2015 and First Addendum to Supply Agreement, Effective As of September 30, 2015 Between NECTAR7 LLC and Chromadex, Inc.
- 31.1 Certification of the Chief Executive Officer Pursuant to ?240.13A?14 or ?240.15D?14 of the Securities Exchange Act of 1934, As Amended
- 31.2 Certification of the Chief Financial Officer Pursuant to ?240.13A?14 or ?240.15D?14 of the Securities Exchange Act of 1934, As Amended
- 32.1 Certification Pursuant to 18 U.s.c. Section 1350 (As Adopted Pursuant to Section 906 of the Sarbanes?oxley Act of 2002)
- Download Excel data file
- View Excel data file
CDXC similar filings
Filing view
External links